US equities |
INTC $64.75 ▼-29.67% AMZN $240.44 ▼-1.37% NVDA $204.47 ▼-4.30% MU $882.71 ▼-5.52% GOOGL $280.33 ▼-1.23% SNDK $1,165.27 ▼-12.39% AMD $503.19 ▼-11.16% SPCX $137.85 ▼-4.20%
FinancialContent

CareDx, Inc. - Common Stock (NQ:CDNA)

87.92 +16.40 (+22.92%)
Delayed Quote Updated: 12:37 PM EDT, Oct 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CareDx, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
News headline image
CareDx Appoints Bryan Riggsbee to Its Board of Directors
From CareDx, Inc.
Via Business Wire
News headline image
Recap: CareDx Q4 Earnings ↗
 
Via Benzinga
News headline image
CareDx Announces Fourth Quarter and Full Year 2023 Financial Results
From CareDx, Inc.
Via Business Wire
News headline image
CareDx to Participate in the Raymond James & Associates’ 45th Annual Institutional Investors Conference
From CareDx, Inc.
Via Business Wire
News headline image
Earnings Outlook For CareDx ↗
 
Via Benzinga
News headline image
CareDx: Q3 Earnings Insights ↗
 
Via Benzinga
News headline image
Earnings Outlook For CareDx ↗
 
Via Benzinga
News headline image
CareDx to Report Fourth Quarter and Full Year 2023 Financial Results
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Showcases Digital Solutions and Pipeline in Cellular Transplant and Therapy Monitoring at the 2024 Tandem Meetings
From CareDx, Inc.
Via Business Wire
News headline image
3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List ↗
These biotech stocks offer investors huge potential in the future. Investors may want to consider these equities to enter the industry. 
Via InvestorPlace
News headline image
CareDx Issues Statement in Patent Infringement Case
From CareDx, Inc.
Via Business Wire
News headline image
Natera Hits A Nearly Two-Year High After Notching A Win In A Patent Battle ↗
The company must pay $57 million in damages, but that's far less than expected. 
Via Investor's Business Daily
Topics Intellectual Property
News headline image
CareDx Adds to AlloSure Kidney and HeartCare Utility and Clinical Data at 2024 American Society of Transplant Surgeons Winter Symposium
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2023
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Joins Forces with the National Foundation for Transplants to Improve Post-Transplant Medication Adherence
From CareDx, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
CareDx Reports Third Quarter 2023 Results
From CareDx, Inc.
Via Business Wire
News headline image
CareDx to Report Third Quarter 2023 Financial Results
From CareDx, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
CareDx Announces CEO Transition
From CareDx, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
CareDx Presents New Data at the American Society for Histocompatibility and Immunogenetics Annual Meeting
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Issues Statement on Supreme Court Decision Regarding Stanford-Licensed Patents
From CareDx, Inc.
Via Business Wire
News headline image
CareDx To Present at the 2023 Cantor Global Healthcare Conference
From CareDx, Inc.
Via Business Wire
News headline image
CareDx To Present at the H.C. Wainwright 25th Annual Global Investment Conference
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Hosts Second Annual MEET Digital Health User Conference to Showcase Latest Innovations to Enhance Transplant Patient Care
From CareDx, Inc.
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023 ↗
 
Via Benzinga
News headline image
CareDx Comments on Issuance of Proposed LCD for Molecular Testing for Solid Allograft Rejection
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Reports Second Quarter 2023 Results
From CareDx, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >